{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:35:15Z","timestamp":1793345715044,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017981","name":"Sysmex Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017981","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Surgeon"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.surge.2022.04.006","type":"journal-article","created":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T16:58:04Z","timestamp":1652115484000},"page":"128-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: The UK SentiMag trial (SMART study)"],"prefix":"10.1016","volume":"21","author":[{"given":"Raghavan","family":"Vidya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4583-459X","authenticated-orcid":false,"given":"Muskaan","family":"Khosla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1815-8928","authenticated-orcid":false,"given":"Siobhan","family":"Laws","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Kaushik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naga A.","family":"Mullapudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Macmillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.surge.2022.04.006_bib1","unstructured":"http:\/\/www.cancerresearchuk.org\/cancer-info\/cancerstats\/world\/incidence\/. Accessed 20\/01\/2021."},{"key":"10.1016\/j.surge.2022.04.006_bib2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1056\/NEJMoa012782","article-title":"A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer","volume":"349","author":"Veronesi","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.surge.2022.04.006_bib3","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1097\/00000658-199409000-00015","article-title":"Lymphatic mapping and sentinel lymphadenectomy for breast cancer","volume":"220","author":"Giuliano","year":"1994","journal-title":"Ann Surg"},{"key":"10.1016\/j.surge.2022.04.006_bib4","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jnci\/djj158","article-title":"Randomized multi- center trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC Trial","volume":"98","author":"Mansel","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.surge.2022.04.006_bib5","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1470-2045(07)70278-4","article-title":"Technical outcomes of sentinel-lymph-node resection and conventional axillary-lymph- node dissection in patients with clinically node-negative breast cancer: results from the NSABP B-32 randomised phase III trial","volume":"8","author":"Krag","year":"2007","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.surge.2022.04.006_bib6","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1097\/SLA.0b013e3181c0e92a","article-title":"Sentinel lymph node biopsy in breast cancer: ten-year results of a randomized control study","volume":"251","author":"Veronesi","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/j.surge.2022.04.006_bib7","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.3390\/cancers2041884","article-title":"Nanoparticles in sentinel lymph node assessment in breast cancer","volume":"2","author":"Johnson","year":"2010","journal-title":"Cancers"},{"key":"10.1016\/j.surge.2022.04.006_bib8","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s11523-009-0118-9","article-title":"Imaging applications of nanotechnology in cancer","volume":"4","author":"Gunasekera","year":"2009","journal-title":"Targeted Oncol"},{"key":"10.1016\/j.surge.2022.04.006_bib9","first-page":"374","article-title":"Applications of nanotechnology in cancer","volume":"9","author":"Johnson","year":"2010","journal-title":"Discov Med"},{"key":"10.1016\/j.surge.2022.04.006_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10549-016-3809-9","article-title":"The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc99 and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies. Breast","volume":"157","author":"Karakatsanis","year":"2016","journal-title":"Cancer Res Treat"},{"issue":"4","key":"10.1016\/j.surge.2022.04.006_bib11","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1245\/s10434-013-3379-6","article-title":"Sentinel node biopsy using a magnetic tracer versus standard technique: the SentiMAG multicentre trial","volume":"21","author":"Douek","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.surge.2022.04.006_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.breast.2014.01.004","article-title":"The Central-European SentiMag study: sentinel lymph node biopsy with superparamagnetic iron oxide (SPIO) vs radioisotope","volume":"23","author":"Thill","year":"2014","journal-title":"Breast"},{"issue":"5","key":"10.1016\/j.surge.2022.04.006_bib13","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1002\/jso.24164","article-title":"Sentinel lymph node identification using superparamagnetic iron oxide particles versus radioisotope: the French Sentimag feasibility trial","volume":"113","author":"Houpeau","year":"2016","journal-title":"J Surg Oncol"},{"issue":"1","key":"10.1016\/j.surge.2022.04.006_bib14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejso.2014.11.006","article-title":"The superparamagnetic iron oxide is equivalent to the Tc99 radiotracer method for identifying the sentinel lymph node in breast cancer","volume":"41","author":"Rubio","year":"2014","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.surge.2022.04.006_bib15","series-title":"Italian multicentre study regarding sentinel node biopsy with superparamagnetic iron oxide versus radioisotope. Poster P153 presented at EBCC-9","author":"Ghilli","year":"2014"},{"key":"10.1016\/j.surge.2022.04.006_bib16","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1159\/000492436","article-title":"New technologies for sentinel lymph node detection","volume":"13","author":"Goyal","year":"2018","journal-title":"Breast Care"},{"issue":"6","key":"10.1016\/j.surge.2022.04.006_bib17","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1245\/s10434-020-09280-1","article-title":"Pilot study evaluating the effects of Magtrace for sentinel node biopsy in breast cancer patients regarding care process optimization, reimbursement, surgical time, and patient comfort compared with standard technetium","volume":"28","author":"Shams","year":"2021","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.surge.2022.04.006_bib18","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1245\/s10434-016-5135-1","article-title":"Use of a magnetic tracer for sentinel lymph node detection in early-stage breast cancer patients: a meta-analysis","volume":"23","author":"Teshome","year":"2016","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"10.1016\/j.surge.2022.04.006_bib19","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1002\/bjs.10283","article-title":"Meta-analysis of sentinel lymph node biopsy in breast cancer using the magnetic technique","volume":"103","author":"Zada","year":"2016","journal-title":"Br J Surg"},{"issue":"11","key":"10.1016\/j.surge.2022.04.006_bib20","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1245\/s10434-019-07577-4","article-title":"SentimagIC: a non-inferiority trial comparing superparamagnetic iron oxide versus technetium-99m and blue dye in the detection of axillary sentinel nodes in patients with early-stage breast cancer","volume":"26","author":"Alvarado","year":"2019","journal-title":"Ann Surg Oncol"}],"container-title":["The Surgeon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1479666X22000634?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1479666X22000634?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:18:01Z","timestamp":1761488281000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1479666X22000634"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S1479666X22000634"],"URL":"https:\/\/doi.org\/10.1016\/j.surge.2022.04.006","relation":{},"ISSN":["1479-666X"],"issn-type":[{"value":"1479-666X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: The UK SentiMag trial (SMART study)","name":"articletitle","label":"Article Title"},{"value":"The Surgeon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.surge.2022.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Royal College of Surgeons of Edinburgh (Scottish charity number SC005317) and Royal College of Surgeons in Ireland. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}